Nuvaira, formerly known as Holaira, is a privately held medical device company that develops minimally invasive products to make breathing easier for patients suffering from obstructive lung diseases.

Nuvaira offers a Lung Denervation System to address chronic obstructive pulmonary diseases by treating overactive airway nerves during a minimally invasive procedure that targets the parasympathetic innervation of the lungs.

Nuvaira was founded in 2008 by Steve Dimmer & Martin Mayse. The company was formerly known as Holaira and changed its name to Nuvaira in June 2017. NUVAIRA has it's headquarter based in Minneapolis, Minnesota.


Nuvaira is developing a novel, catheter-based system to address chronic obstructive pulmonary disease, or COPD, by treating the overactive airway nerves in a procedure call Targeted Lung Denervation* (TLD). 


Nuvaira is backed by investors including U.S. Venture Partners (USVP), Vertex Ventures, Vertex Ventures HC, & Advanced Technology Ventures among others.



  • Year founded: 2008
  • Funding Info: $147.6M in 7 Funding Rounds (Last Funding Type: Series E)
  • Yearly Revenue: $10M-$20M (2018)
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Minneapolis
  • State: Minnesota
  • Country: United States
Related businesses